Cargando…

Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability

BACKGROUND: Transcription factor c-Myc plays a critical role in various physiological and pathological events. c-Myc gene rearrangement is closely associated with multiple myeloma (MM) progression and drug resistance. Thereby, targeting c-Myc is expected to be a useful therapeutic strategy for hemat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Ruosi, Zhang, Menghui, Zhou, Jian, Liu, Linlin, Zhang, Yan, Gao, Jian, Xu, Kailin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137135/ https://www.ncbi.nlm.nih.gov/pubmed/35619182 http://dx.doi.org/10.1186/s12964-022-00868-6

Ejemplares similares

Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma
por: Yao, Ruosi, et al.
Publicado: (2020)

Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cells
por: Yao, Ruosi, et al.
Publicado: (2018)

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells
por: Singh, Ashutosh, et al.
Publicado: (2021)

Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
por: Wang, Jiandong, et al.
Publicado: (2014)

MYC–MAX heterodimerization is essential for the induction of major zygotic genome activation and subsequent preimplantation development
por: Yamamoto, Takuto, et al.
Publicado: (2023)

Myc interacts with Max and Miz1 to repress C/EBPδ promoter activity and gene expression
por: Si, Junling, et al.
Publicado: (2010)

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2013)

Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2018)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis
por: Mathsyaraja, Haritha, et al.
Publicado: (2019)

A Combinatorial Code for CPEB-Mediated c-myc Repression
por: Ogami, Koichi, et al.
Publicado: (2023)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010)

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
por: Castell, Alina, et al.
Publicado: (2022)

Gfi1 upregulates c-Myc expression and promotes c-Myc-driven cell proliferation
por: Zhang, Yangyang, et al.
Publicado: (2020)

MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021)

Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
por: Ibrahim, Dina, et al.
Publicado: (2022)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
por: Cao, Yang, et al.
Publicado: (2021)

The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020)

Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments
por: Zhou, Jian, et al.
Publicado: (2021)

Mnt–Max to Myc–Max complex switching regulates cell cycle entry
por: Walker, William, et al.
Publicado: (2005)

The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities
por: Montagne, Martin, et al.
Publicado: (2012)

A statin-regulated microRNA represses human c-Myc expression and function
por: Takwi, Apana A L, et al.
Publicado: (2012)

Structural basis of JAZ repression of MYC transcription factors in jasmonate signaling
por: Zhang, Feng, et al.
Publicado: (2015)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
por: Xu, Xinyuan, et al.
Publicado: (2015)

Humanized c-Myc Mouse
por: Lehmann, Frank M., et al.
Publicado: (2012)

Targeting c-MYC with T-Cells
por: Helm, Florian, et al.
Publicado: (2013)

Getting to grips with c-Myc
por: Eick, Dirk
Publicado: (2018)

MYC dysregulation in the progression of multiple myeloma
por: Misund, K, et al.
Publicado: (2019)

Anaplastic multiple myeloma with MYC rearrangement
por: Ichikawa, Satoshi, et al.
Publicado: (2021)

Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia
por: Sodaro, Gaetano, et al.
Publicado: (2017)

c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53
por: Kaller, Markus, et al.
Publicado: (2023)

A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
por: Xu, Ying, et al.
Publicado: (2022)

ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
por: Chen, Junru, et al.
Publicado: (2020)

MYC-Associated Factor MAX is a Regulator of the Circadian Clock
por: Blaževitš, Olga, et al.
Publicado: (2020)

Zwint facilitates melanoma progression by promoting c-Myc expression
por: Mou, Kuanhou, et al.
Publicado: (2021)

Cuproptosis engages in c-Myc-mediated breast cancer stemness
por: Wang, Runtian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k3l80j7qpjua1428a6f1tnd9e5